Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype.

Acute myeloid leukemia (AML) is a biologically and clinically heterogeneous disease with disparate outcome. Underlying cytogenetic and molecular aberrations stand for the most important prognostic ...